Search research articles
Contact Us
Filters
Showing results (131-140 of 139) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 139 results.
Molecules (Basel, Switzerland)
|
October 13, 2021
l-Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in Cells
Luca Sancineto, Carmine Ostacolo, David Ortega-Alarcon, et al.
Frontiers in Public Health
|
May 27, 2026
Challenges to continuity of care among patients with long COVID-related taste and smell disorders: a qualitative study
María Belén Martín-Sanz, Paloma Moro-López-Menchero, César Fernández-De-Las-Peñas, et al.
International Dental Journal
|
April 4, 2026
Minimum Intervention Oral Care (MIOC) - Overcoming Implementation Barriers: An International Expert Consensus
Falk Schwendicke, Avijit Banerjee, Sarah R Baker, et al.
Cell Death & Disease
|
June 30, 2017
Inefficient differentiation response to cell cycle stress leads to genomic instability and malignant progression of squamous carcinoma cells
Pilar Alonso-Lecue, Isabel de Pedro, Vincent Coulon, et al.
Nature Chemical Biology
|
January 15, 2020
Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3
Matilde de Las Rivas, Earnest James Paul Daniel, Yoshiki Narimatsu, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M<sup>pro</sup> and Its Antiviral Activity in Cells against SARS-CoV-2
Francesca Mangiavacchi, Pawel Botwina, Elena Menichetti, et al.
Eclinicalmedicine
|
August 31, 2021
Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]"
Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, et al.
Eclinicalmedicine
|
June 30, 2021
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial
Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, et al.
Journal of Dentistry
|
November 7, 2022
RoBDEMAT: A risk of bias tool and guideline to support reporting of pre-clinical dental materials research and assessment of systematic reviews
António Hs Delgado, Salvatore Sauro, Adriano F Lima, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 139) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 139 results.
Molecules (Basel, Switzerland)
|
October 13, 2021
l-Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in Cells
Luca Sancineto, Carmine Ostacolo, David Ortega-Alarcon, et al.
Frontiers in Public Health
|
May 27, 2026
Challenges to continuity of care among patients with long COVID-related taste and smell disorders: a qualitative study
María Belén Martín-Sanz, Paloma Moro-López-Menchero, César Fernández-De-Las-Peñas, et al.
International Dental Journal
|
April 4, 2026
Minimum Intervention Oral Care (MIOC) - Overcoming Implementation Barriers: An International Expert Consensus
Falk Schwendicke, Avijit Banerjee, Sarah R Baker, et al.
Cell Death & Disease
|
June 30, 2017
Inefficient differentiation response to cell cycle stress leads to genomic instability and malignant progression of squamous carcinoma cells
Pilar Alonso-Lecue, Isabel de Pedro, Vincent Coulon, et al.
Nature Chemical Biology
|
January 15, 2020
Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3
Matilde de Las Rivas, Earnest James Paul Daniel, Yoshiki Narimatsu, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M<sup>pro</sup> and Its Antiviral Activity in Cells against SARS-CoV-2
Francesca Mangiavacchi, Pawel Botwina, Elena Menichetti, et al.
Eclinicalmedicine
|
August 31, 2021
Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]"
Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, et al.
Eclinicalmedicine
|
June 30, 2021
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial
Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, et al.
Journal of Dentistry
|
November 7, 2022
RoBDEMAT: A risk of bias tool and guideline to support reporting of pre-clinical dental materials research and assessment of systematic reviews
António Hs Delgado, Salvatore Sauro, Adriano F Lima, et al.
Page
of 14